Emergency Medicine Patient Safety Group Publishes Briefing on Safe Injection Practices The Emergency Medicine Patient Safety Foundation has released a briefing on safe injection practices, including ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings.
DENVER - A new study sheds light on the critical ability of individuals with an adrenal crisis to complete emergency cortisol injections. This research, published in Endocrine Practice(Opens in a new ...
GLENDALE HEIGHTS, Ill.--(BUSINESS WIRE)--Medefil, Inc., a domestic manufacturer of injectable products, has announced availability of its FDA-approved ANDA products, Atropine Sulfate Injection, USP, 1 ...
Nearly 60% of patients with adrenal insufficiency and their caregivers needed to administer emergency glucocorticoid injections, yet more than one third failed, resulting in negative outcomes.
Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings. Researchers are now conducting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results